Biblio

Export 417 results:
Author [ Title(Asc)] Type Year
Filters: First Letter Of Keyword is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
N. Carcavilla, Pozo, A. Sofía, González, B., Moral-Cuesta, D., Roldán, J. Joaquín, Erice, V., and Remírez, Ade Ganuza, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
B. T. Hyman, Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., Nelson, P. T., Schneider, J. A., Thal, D. Rudolf, Thies, B., Trojanowski, J. Q., Vinters, H. V., and Montine, T. J., “National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease.”, Alzheimers Dement, vol. 8, no. 1, pp. 1-13, 2012.
M
E. Zupanic, von Euler, M., Winblad, B., Xu, H., Secnik, J., Kramberger, M. Gregoric, Religa, D., Norrving, B., and Garcia-Ptacek, S., “Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1253-1261, 2021.
E. Zupanic, von Euler, M., Winblad, B., Xu, H., Secnik, J., Kramberger, M. Gregoric, Religa, D., Norrving, B., and Garcia-Ptacek, S., “Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1253-1261, 2021.
M. Chakrabarti, McDonald, A. J., J Reed, W., Moss, M. A., Das, B. C., and Ray, S. K., “Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 2, pp. 335-52, 2016.
M. Edwards, Hall, J., Williams, B., Johnson, L., and O'Bryant, S., “Molecular markers of amnestic mild cognitive impairment among Mexican Americans.”, J Alzheimers Dis, vol. 49, no. 1, pp. 221-8, 2016.
Y. Huang, Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W. - X., and Zhang, Y. - X., “Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 885-897, 2017.
Y. Huang, Shen, W., Su, J., Cheng, B., Li, D., Liu, G., Zhou, W. - X., and Zhang, Y. - X., “Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity.”, J Alzheimers Dis, vol. 57, no. 3, pp. 885-897, 2017.
E. M. Elzayat, Shahien, S. A., El-Sherif, A. A., and Hosney, M., “miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S203-S225, 2023.
E. M. Elzayat, Shahien, S. A., El-Sherif, A. A., and Hosney, M., “miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S203-S225, 2023.
K. Dhana, James, B. D., Agarwal, P., Aggarwal, N. T., Cherian, L. J., Leurgans, S. E., Barnes, L. L., Bennett, D. A., and Schneider, J. A., “MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.”, J Alzheimers Dis, vol. 83, no. 2, pp. 683-692, 2021.
D. S Han, Boyle, P. A., James, B. D., Yu, L., and Bennett, D. A., “Mild Cognitive Impairment and Susceptibility to Scams in Old Age.”, J Alzheimers Dis, vol. 49, no. 3, pp. 845-51, 2016.
J. A. Luchsinger, Perez, T., Chang, H., Mehta, P., Steffener, J., Pradabhan, G., Ichise, M., Manly, J., Devanand, D. P., and Bagiella, E., “Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial.”, J Alzheimers Dis, vol. 51, no. 2, pp. 501-14, 2016.
S. Min Son, Shin, H. - J., Byun, J., Kook, S. Young, Moon, M., Chang, Y. Jin, and Mook-Jung, I., “Metformin Facilitates Amyloid-β Generation by β- and γ-Secretases via Autophagy Activation.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1197-208, 2016.
S. - S. Wang, Jia, J., and Wang, Z., “Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1005-1013, 2018.
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., “Memory impairment in transgenic Alzheimer mice requires cellular prion protein.”, J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., “Memory impairment in transgenic Alzheimer mice requires cellular prion protein.”, J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
R. Langlois, Joubert, S., Benoit, S., Dostie, V., and Rouleau, I., “Memory for Public Events in Mild Cognitive Impairment and Alzheimer's Disease: The Importance of Rehearsal.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1023-33, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P., “MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”, J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
S. M. de la Monte, “Malignant Brain Aging: The Formidable Link Between Dysregulated Signaling Through Mechanistic Target of Rapamycin Pathways and Alzheimer's Disease (Type 3 Diabetes).”, J Alzheimers Dis, vol. 95, no. 4, pp. 1301-1337, 2023.
L
F. Huang, Shang, Y., Luo, Y., Wu, P., Huang, X., Tan, X., Lu, X., Zhen, L., and Hu, X., “Lower Prevalence of Alzheimer's Disease among Tibetans: Association with Religious and Genetic Factors.”, J Alzheimers Dis, vol. 50, no. 3, pp. 659-67, 2016.
G. Cuberas-Borrós, Roca, I., Boada, M., Tárraga, L., Hernandez, I., Buendia, M., Rubio, L., Torres, G., Bittini, Á., Guzmán-de-Villoria, J. A., Pujadas, F., Torres, M., Núñez, L., Castell, J., and Páez, A., “Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.”, J Alzheimers Dis, vol. 61, no. 1, pp. 321-332, 2018.
J. Riancho, Pozueta, A., Santos, M., Lage, C., Carril, J. M., Banzo, I., Martínez-Rodriguez, I., Gorno-Tempini, M., and Sánchez-Juan, P., “Logopenic Aphasia due to a Strategic Stroke: New Evidence from a Single Case.”, J Alzheimers Dis, vol. 57, no. 3, pp. 717-721, 2017.

Pages